Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Autocrine expression of both endostatin and green fluorescent protein provides a synergistic antitumor effect in a murine neuroblastoma model

Cancer Gene Therapy volume 8, pages 537–545 (2001)Cite this article

Abstract

Modalities that act through different mechanisms can often provide synergistic antitumor activity for the treatment of refractory tumors when used in combination. Here we report a gene therapy approach in which the genes for the angiogenesis inhibitor, endostatin, and the marker protein and potent immunogen, green fluorescent protein (GFP), were delivered to murine neuroblastoma cells prior to inoculation of the tumor cells into syngeneic immunocompetent mice. Although the effect of either angiogenesis inhibition or immunomodulation alone resulted in only a modest delay in tumor growth, when these approaches were used in combination, prevention of the formation of appreciable tumors was effected in 15 of 24 (63%) mice. The combination of endostatin and GFP expression elicited a strong immune response that was T cell–mediated and was reactive against both GFP and tumor cell line–specific antigens. This afforded treated mice protection against subsequent tumor challenge with unmodified tumor cells. These results suggest that antiangiogenic and immunotherapy strategies, when used in a gene therapy–mediated approach, can act synergistically in an effective multimodality anticancer approach. Cancer Gene Therapy (2001) 8, 537–545

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Folkman J . The role of angiogenesis in tumor growth Semin Cancer Biol 1992 3: 65–71

    CAS  PubMed  Google Scholar 

  2. Bicknell R, Harris AL . Mechanisms and therapeutic implications of angiogenesis Curr Opin Oncol 1996 8: 60–65

    Article  CAS  PubMed  Google Scholar 

  3. Pluda JM . Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies Semin Oncol 1997 24: 203–218

    CAS  PubMed  Google Scholar 

  4. Folkman J, Ingber D . Inhibition of angiogenesis Semin Cancer Biol 1992 3: 89–96

    CAS  PubMed  Google Scholar 

  5. Bicknell R, Harris AL . Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis Semin Cancer Biol 1992 3: 399–407

    CAS  PubMed  Google Scholar 

  6. Scott PAE, Harris AL . Current approaches to targeting cancer using antiangiogenesis therapies Cancer Treat Rev 1994 20: 393–412

    Article  CAS  PubMed  Google Scholar 

  7. O'Reilly MS, Boehm T, Shing Y, et al . Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 1997 88: 277–285

    Article  CAS  PubMed  Google Scholar 

  8. Dhanabal M, Ramchandran R, Waterman MJF, et al . Endostatin induces endothelial cell apoptosis J Biol Chem 1999 274: 11721–11726

    Article  CAS  PubMed  Google Scholar 

  9. Dhanabal M, Ramchandran R, Ruediger V, et al . Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma Cancer Res 2000 59: 189–197

    Google Scholar 

  10. Perletti G, Concari P, Giardini R, et al . Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors Cancer Res 2000 60: 1793–1796

    CAS  PubMed  Google Scholar 

  11. Boehm T, Folkman J, Browder T, et al . Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 1997 390: 404–407

    Article  CAS  PubMed  Google Scholar 

  12. O'Reilly MS, Holmgren L, Chen C, et al . Angiostatin induces and sustains dormancy of human primary tumors in mice Nat Med 1996 2: 689–692

    Article  CAS  PubMed  Google Scholar 

  13. Weber JS, Jay G, Tanaka K, et al . Immunotherapy of a murine tumor with interleukin-2 J Exp Med 1987 166: 1716–1733

    Article  CAS  PubMed  Google Scholar 

  14. Lord EM, Frelinger JG . Tumor immunotherapy: cytokines and antigen presentation Cancer Immunol Immunother 1998 46: 75–81

    Article  CAS  PubMed  Google Scholar 

  15. Cheung NK . Immunotherapy. Neuroblastoma as a model Pediatr Clin North Am 1991 38: 425–441

    Article  CAS  PubMed  Google Scholar 

  16. Hock RA, Reynolds BD, Tucker-McClung CL, et al . Human class II major histocompatibility complex gene transfer into murine neuroblastoma leads to loss of tumorigenicity, immunity against subsequent tumor challenge, and elimination of microscopic preestablished tumors J Immunother 1995 17: 12–18

    Article  CAS  Google Scholar 

  17. Greten TF, Jaffee EM . Cancer vaccines Blood 1999 17: 1047–1060

    CAS  Google Scholar 

  18. Stripecke R, Villacres MdC, Skelton DC, et al . Immune response to green fluorescent protein: implications for gene therapy Gene Ther 1999 6: 1305–1312

    Article  CAS  PubMed  Google Scholar 

  19. Lode HN, Xiang R, Varki NM, et al . Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow J Natl Cancer Inst 1997 98: 1586–1594

    Article  Google Scholar 

  20. Dubridge RB, Tang P, Hsia HC, et al . Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system Mol Cell Biol 1987 7: 739–745

    Article  Google Scholar 

  21. Rehn M, Pihlajaniemi T . Identification of three N-terminal ends of type XVIII collagen chains and tissue-specific differences in the expression of the corresponding transcripts J Biol Chem 1995 270,9: 4705–4711

    Article  Google Scholar 

  22. Smith TAG, Mehaffey MG, Kayda BD, et al . Adenovirus-mediated expression of therapeutic plasma levels of human factor IX in mice Nat Genet 1993 5: 397–402

    Article  CAS  PubMed  Google Scholar 

  23. Persons DA, Allay JA, Allay ER, et al . Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis Blood 1999 93: 488–499

    CAS  PubMed  Google Scholar 

  24. Migita M, Medin JA, Pawliuk R, et al . Selection of transduced CD34 + progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors Proc Natl Acad Sci USA 1995 92: 12075–12080

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Skidgel RA, Erdos EG . Cellular carboxypeptidases Immunol Rev 1998 161: 129–141

    Article  CAS  PubMed  Google Scholar 

  26. Persons DA, Mehaffey MG, Kaleko M, et al . An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene Blood Cells, Mol, Dis 1998 24: 167–182

    Article  CAS  Google Scholar 

  27. Yang Y, Vanin EF, Whitt MA, et al . Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis Virus G envelope protein Hum Gene Ther 1995 6: 1203–1213

    Article  CAS  PubMed  Google Scholar 

  28. Sarmiento M, Glasebrook AL, Fitch FW . IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement J Immunol 1980 125: 2665–2672

    CAS  PubMed  Google Scholar 

  29. Dialynas DP, Quan ZS, Wall KA, et al . Characterization of the murine T-cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule J Immunol 1983 131: 2445–2451

    CAS  PubMed  Google Scholar 

  30. Yamaguchi N, Anand-Apte B, Lee M, et al . Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding EMBO J 1999 16: 4414–4423

    Article  Google Scholar 

  31. Yoon SS, Eto H, Lin C, et al . Mouse endostatin inhibits the formation of lung and liver metastases Cancer Res 1999 59: 6251–6256

    CAS  PubMed  Google Scholar 

  32. Blezinger P, Wang J, Gondo M, et al . Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene Nat Biotechnol 1999 17: 343–348

    Article  CAS  PubMed  Google Scholar 

  33. Sauter BV, Martinet O, Zhang WJ, et al . Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases Proc Natl Acad Sci USA 2000 97: 4802–4807

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Feldman AL, Restifo NP, Alexander R, et al . Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice Cancer Res 2000 60: 1503–1506

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Assisi Foundation of Memphis 94-000, Grant IRG-87-008-09 from the American Cancer Society, Cancer Center Support CORE Grant P30 CA 21765, and American Lebanese Syrian Associated Charities.

Author information

Authors and Affiliations

  1. Department of Surgery, St. Jude Children's Research Hospital and University of Tennessee College of Medicine, Memphis, Tennessee

    Andrew M Davidoff, Catherine Y C Ng & William W Spurbeck

  2. Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee

    Margaret A Leary, Pascale Frare, Marc Vanhove, Arthur W Nienhuis & Elio F Vanin

Authors
  1. Andrew M Davidoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margaret A Leary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Catherine Y C Ng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William W Spurbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pascale Frare
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marc Vanhove
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Arthur W Nienhuis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Elio F Vanin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew M Davidoff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davidoff, A., Leary, M., Ng, C. et al. Autocrine expression of both endostatin and green fluorescent protein provides a synergistic antitumor effect in a murine neuroblastoma model. Cancer Gene Ther 8, 537–545 (2001). https://doi.org/10.1038/sj.cgt.7700346

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700346

Keywords

This article is cited by

Search

Advanced search

Quick links